Humana (HUM) Stock Price
Humana Price
Over the last 19 years Humana grew revenue by 9.9% annually, reaching 129.66 B USD. Earnings per share have grown at 6.7% per year over the last 19 years. For Humana, the net margin of 0.9% is down versus 3.5% a few years ago. At today's price the dividend yield works out to roughly 0.85%. The payout ratio is around 36% of earnings. The dividend has grown at 11.7% per year over the past 14 years. The consensus 12-month price target for Humana is 412.50 USD, about 1.3% below where the stock trades today. Of 33 analysts, 16 rate the stock a buy — an overall Hold consensus.
Humana stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Humana business model & stock analysis
Frequently asked questions about Humana
The business model of Humana Inc is focused on providing healthcare services to individuals and families. As a leading health insurance company, Humana offers a wide range of health insurance plans and services including Medicare, Medicaid, and commercial plans. The company aims to improve the health and wellbeing of its members by offering access to quality healthcare, working closely with healthcare providers, and promoting preventive care and wellness programs. With a strong commitment to innovation and technology, Humana strives to enhance the overall healthcare experience for its members while driving value and affordability in healthcare delivery.
Humana Inc is primarily active in the healthcare industry. With a focus on offering a wide range of health insurance products and services, Humana serves individuals, employers, military service members, and their families. The company provides various medical and specialty health products, including Medicare Advantage plans, prescription drug plans, dental, vision, and wellness programs. With an extensive network of healthcare providers, Humana aims to improve the health and well-being of its members by delivering personalized and comprehensive healthcare solutions. As one of the leading healthcare companies, Humana Inc plays a crucial role in the provision of accessible and quality healthcare services.
The main competitors of Humana Inc in the market include UnitedHealth Group Incorporated, Anthem, Inc., and CVS Health Corporation.
Humana Inc is a leading healthcare company founded in 1961 and headquartered in Louisville, Kentucky. With a rich history spanning over five decades, Humana has emerged as a trusted name in the industry. Originally a nursing home business, Humana quickly expanded its operations to provide comprehensive health insurance services. Today, it offers a wide range of healthcare products and services, including Medicare and Medicaid plans, commercial health insurance, and specialty benefits. Through strategic acquisitions and partnerships, Humana has consistently grown its presence, providing innovative and accessible healthcare solutions to millions of customers across the United States. The company's commitment to customer-centric care and its extensive industry experience have solidified Humana Inc's position as a prominent player in the healthcare sector.
Humana Inc, a renowned healthcare company, has achieved several significant milestones throughout its history. One notable achievement was the company's inclusion in the Fortune 500 list, highlighting its position among the top-ranked businesses in the United States. Additionally, Humana Inc has consistently expanded its presence and diversified its offerings, successfully establishing itself as a leading provider of health insurance, wellness programs, and healthcare services. The company has also been recognized for its commitment to innovation, earning accolades for its progressive approach to healthcare delivery. Humana Inc's dedication to improving customer satisfaction and promoting healthy living has contributed to its widespread success in the industry.
Humana Inc is primarily present in the United States.
Humana Inc is committed to enhancing the well-being of people and making healthcare more accessible. The company's corporate philosophy revolves around delivering value-based care, focusing on the whole person, and improving the health outcomes of its members. Humana prioritizes innovation and technology to provide personalized and affordable healthcare solutions. With a focus on preventive care and wellness programs, Humana aims to empower individuals to live healthier lives. By fostering a culture of inclusion, collaboration, and integrity, Humana strives to be a trusted partner for its members, employees, and communities it serves.
Analysts currently set an average price target of 416.78 USD for the Humana stock (median: 412.50 USD), implying +1.1 % versus the latest price. The consensus is based on 33 analyst ratings.
33 analysts currently rate the Humana stock: 16 recommend buying, 16 holding and 1 selling. For 2026, analysts expect Humana to generate revenue of 162.52 B USD and earnings per share of 9.14 USD.
Converted at the current exchange rate, the Humana share trades at 372.28 EUR (417.89 USD).
The Humana share (HUM) is listed on 7 stock exchanges, including: NYSE (HUM), London (0J6Z.L), SIX (Zürich) (HUM.SW), Frankfurt (HUM.F), München (HUM.MU), Düsseldorf (HUM.DU).
Humana Inc is a global healthcare company based in Louisville, Kentucky. It offers various products and services in healthcare, health insurance, and lifelong health solutions. They provide insurance for different areas such as medical, dental, vision, and travel. Additionally, they have specialized insurance plans for seniors and people with chronic illnesses. Humana also operates clinics and medical centers, offering a wide range of medical services including prevention, diagnosis, and treatment. They invest in research and development of medical technologies to improve healthcare. In terms of lifelong health solutions, Humana has programs like Humana GO365 that reward healthy behaviors. They also operate pharmacies and offer specialized pharmacy services. Humana's business model aims to provide tailored health solutions and insurance products to meet each customer's needs.
The expected revenue of Humana is 162.52 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Humana is 1.10 B USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Humana is currently 45.74. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Humana stock.
The price-to-sales ratio (P/S) of Humana is currently 0.31. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Humana stock.
The Eulerpool Quality Score for Humana is 5/10.
The ISIN of Humana is US4448591028. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Humana is 856584. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Humana is HUM. The ticker symbol is used to trade Humana shares on the stock exchange.
Humana stock
Humana Ticker
Humana FIGI
All fundamentals and in-depth analysis of Humana
Our stock analysis for Humana stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Humana. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.